Daclatasvir-Natdac

Shubham Pharmaceuticals
Daclatasvir-Natdac
Product Code : 45
 
Product Description

DACLATASVIR :

NATDAC contains the Drug / Molecule Daclatasvir.

 

USAGE & DESCRIPTION :

NATDAC has used with sofosbuvir for the treatment of patients with chronic hepatitis c virus (hcv) genotype 1 or genotype 3 infection

Active Ingredients

Daclatasvir

Brand Name

Natdac

International Brand Name

Daklinza

Packing

1*28

Doses Form

Tablets (IN Plastic Bottle)

Strength

30 Mg & 60 Mg

Mfg By

Natco Pharma Limited (INDIA)

 

CLINICAL APPLICATIONS :

It inhibits the Hepatitis C Virus (HCV) nonstructural protein by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

 

STORAGE :

Store below 25°C.

 
Trade Information
  • Main Export Market(s)
  • Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia